407 related articles for article (PubMed ID: 26645385)
1. Risk of Occult Uterine Sarcoma in Presumed Uterine Fibroids.
Cui RR; Wright JD
Clin Obstet Gynecol; 2016 Mar; 59(1):103-18. PubMed ID: 26645385
[TBL] [Abstract][Full Text] [Related]
2. Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women.
Lieng M; Berner E; Busund B
J Minim Invasive Gynecol; 2015; 22(3):410-4. PubMed ID: 25460521
[TBL] [Abstract][Full Text] [Related]
3. Risk of Undetected Cancer at the Time of Laparoscopic Supracervical Hysterectomy and Laparoscopic Myomectomy: Implications for the Use of Power Morcellation.
Perkins RB; Handal-Orefice R; Hanchate AD; Lin M; Paasche-Orlow MK
Womens Health Issues; 2016; 26(1):21-6. PubMed ID: 26701205
[TBL] [Abstract][Full Text] [Related]
4. Incidence of sarcoma in patients undergoing hysterectomy for benign indications: a population-based study.
Multinu F; Casarin J; Tortorella L; Huang Y; Weaver A; Angioni S; Melis GB; Mariani A; Stewart EA; Laughlin-Tommaso SK
Am J Obstet Gynecol; 2019 Feb; 220(2):179.e1-179.e10. PubMed ID: 30447212
[TBL] [Abstract][Full Text] [Related]
5. What is the Future of Open Intraperitoneal Power-Morcellation of Fibroids?
Parker WH; Pritts EA; Olive DL
Clin Obstet Gynecol; 2016 Mar; 59(1):73-84. PubMed ID: 26670834
[TBL] [Abstract][Full Text] [Related]
6. Risk of unexpected uterine leiomyosarcoma during laparoscopic procedures: Experience from a single tertiary institute in Italy.
Surace A; BaĆ¹ MG; Privitera S; Botta G; Danese S; Plazzotta C; Mitidieri M; Picardo E
Int J Gynaecol Obstet; 2022 Feb; 156(2):236-239. PubMed ID: 33834486
[TBL] [Abstract][Full Text] [Related]
7. Does fibroids surgery by endoscopy or laparotomy represent a malignancy threat?
Mettler L; Abdusattarova K; Alkatout I
Minerva Ginecol; 2017 Dec; 69(6):517-525. PubMed ID: 28696085
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, characteristics, and risk factors of occult uterine cancer in presumed benign hysterectomy.
Desai VB; Wright JD; Gross CP; Lin H; Boscoe FP; Hutchison LM; Schwartz PE; Xu X
Am J Obstet Gynecol; 2019 Jul; 221(1):39.e1-39.e14. PubMed ID: 30853364
[TBL] [Abstract][Full Text] [Related]
9. Assessing the risk of laparoscopic morcellation of occult uterine sarcomas during hysterectomy and myomectomy: Literature review and the ISGE recommendations.
Sizzi O; Manganaro L; Rossetti A; Saldari M; Florio G; Loddo A; Zurawin R; van Herendael B; Djokovic D
Eur J Obstet Gynecol Reprod Biol; 2018 Jan; 220():30-38. PubMed ID: 29149644
[TBL] [Abstract][Full Text] [Related]
10. Occult Leiomyosarcomas in a Canadian Province: A Retrospective Cohort Study.
Wu CQ; Woo LY; Giede KC; Thiel J; Karreman E; Rattray DD
J Obstet Gynaecol Can; 2019 Jan; 41(1):46-51. PubMed ID: 30341020
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and management experience of unexpected uterine sarcoma after myomectomy.
Zhang J; Zhang J; Dai Y; Zhu L; Lang J; Leng J
Int J Gynaecol Obstet; 2015 Aug; 130(2):195-9. PubMed ID: 26117552
[TBL] [Abstract][Full Text] [Related]
12. Laparoscopic Hysterectomy for Uterine Fibroids: Is it Safe?
Hinchcliff EM; Cohen SL
Clin Obstet Gynecol; 2016 Mar; 59(1):66-72. PubMed ID: 26670837
[TBL] [Abstract][Full Text] [Related]
13. Uterine Sarcomas in Patients Undergoing Surgery for Presumed Leiomyomas: 10 Years' Experience.
Paul PG; Rengaraj V; Das T; Garg R; Thomas M; Khurd AS
J Minim Invasive Gynecol; 2016; 23(3):384-9. PubMed ID: 26677821
[TBL] [Abstract][Full Text] [Related]
14. No. 371-Morcellation During Gynaecologic Surgery: Its Uses, Complications, and Risks of Unsuspected Malignancy.
Murji A; Scott S; Singh SS; Bougie O; Leyland N; Laberge PY; Vilos GA
J Obstet Gynaecol Can; 2019 Jan; 41(1):116-126. PubMed ID: 30580824
[TBL] [Abstract][Full Text] [Related]
15. Incidence of occult leiomyosarcoma in presumed morcellation cases: a database study.
Rodriguez AM; Zeybek B; Asoglu MR; Sak ME; Tan A; Borahay MA; Kilic GS
Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():31-5. PubMed ID: 26699101
[TBL] [Abstract][Full Text] [Related]
16. Laparoscopic hysterectomy with morcellation vs abdominal hysterectomy for presumed fibroids: an updated decision analysis following the 2014 Food and Drug Administration safety communications.
Siedhoff MT; Doll KM; Clarke-Pearson DL; Rutstein SE
Am J Obstet Gynecol; 2017 Mar; 216(3):259.e1-259.e6. PubMed ID: 27890646
[TBL] [Abstract][Full Text] [Related]
17. Uterine leiomyosarcoma - incidence, treatment, and the impact of morcellation. A nationwide cohort study.
Skorstad M; Kent A; Lieng M
Acta Obstet Gynecol Scand; 2016 Sep; 95(9):984-90. PubMed ID: 27223683
[TBL] [Abstract][Full Text] [Related]
18. Occult Uterine Sarcoma and Leiomyosarcoma: Incidence of and Survival Associated With Morcellation.
Raine-Bennett T; Tucker LY; Zaritsky E; Littell RD; Palen T; Neugebauer R; Axtell A; Schultze PM; Kronbach DW; Embry-Schubert J; Sundang A; Bischoff K; Compton-Phillips AL; Lentz SE
Obstet Gynecol; 2016 Jan; 127(1):29-39. PubMed ID: 26646120
[TBL] [Abstract][Full Text] [Related]
19. Association Between Power Morcellation and Mortality in Women With Unexpected Uterine Cancer Undergoing Hysterectomy or Myomectomy.
Xu X; Lin H; Wright JD; Gross CP; Boscoe FP; Hutchison LM; Schwartz PE; Desai VB
J Clin Oncol; 2019 Dec; 37(35):3412-3424. PubMed ID: 31518176
[TBL] [Abstract][Full Text] [Related]
20. Unexpected uterine sarcomas in 4478 patients with electric power morcellation for leiomyomas.
Chen Q; Shi H; Lu W; Lu B
Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():85-89. PubMed ID: 30245442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]